Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (403)
Shares
10,000
Price
$0.06
Total Value
$590.00
Shares Held After
9,365,456
% of Holdings
0.1%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
31,031
Price
$20.05
Total Value
$622.32K
Shares Held After
39,900
% of Holdings
43.7%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
900
Price
$63.86
Total Value
$57.47K
Shares Held After
61,500
% of Holdings
1.4%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
4,100
Price
$63.27
Total Value
$259.39K
Shares Held After
62,400
% of Holdings
6.2%
Surgery Partners, Inc. (SGRY)
DeLuca Teresa — Director
Shares
10,000
Price
$14.35
Total Value
$143.50K
Shares Held After
66,843
% of Holdings
15.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
441
Price
$518.65
Total Value
$228.72K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,630
Price
$518.19
Total Value
$844.64K
Shares Held After
324,884
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
873
Price
$517.09
Total Value
$451.42K
Shares Held After
326,514
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,880
Price
$516.04
Total Value
$970.16K
Shares Held After
327,387
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,333
Price
$514.99
Total Value
$1.20M
Shares Held After
329,267
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,264
Price
$514.18
Total Value
$649.92K
Shares Held After
331,600
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
439
Price
$513.06
Total Value
$225.23K
Shares Held After
332,864
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
170
Price
$511.59
Total Value
$86.97K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
231
Price
$510.47
Total Value
$117.92K
Shares Held After
333,473
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$509.48
Total Value
$121.77K
Shares Held After
333,704
% of Holdings
0.1%
SeaStar Medical Holding Corp (ICU)
Messinger Michael — Chief Financial Officer
Shares
750
Price
$3.27
Total Value
$2.45K
Shares Held After
2,500
% of Holdings
30.0%
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Greenway Nicola Deidre Petal — Chief Human Resources Officer
Shares
12,980
Price
$18.11
Total Value
$235.12K
Shares Held After
40,049
% of Holdings
24.5%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP&Chairman, Partnering
Shares
100,000
Price
$59.97
Total Value
$6.00M
Shares Held After
370,401
% of Holdings
21.3%
UFP TECHNOLOGIES INC (UFPT)
Hudson Symeria — Director
Shares
298
Price
$319.11
Total Value
$95.09K
Shares Held After
927
% of Holdings
24.3%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$13.86
Total Value
$859.32K
Shares Held After
1,325,695
% of Holdings
4.5%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
31,801
Price
$37.18
Total Value
$1.18M
Shares Held After
18,630,739
% of Holdings
0.2%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
105,141
Price
$36.59
Total Value
$3.85M
Shares Held After
18,630,739
% of Holdings
0.6%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
30,706
Price
$0.84
Total Value
$25.88K
Shares Held After
283,774
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
145
Price
$32.47
Total Value
$4.71K
Shares Held After
21,225
% of Holdings
0.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
2,716
Price
$32.01
Total Value
$86.93K
Shares Held After
21,370
% of Holdings
11.3%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
178,937
% of Holdings
9.3%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
17,043
Price
$0.84
Total Value
$14.37K
Shares Held After
178,765
% of Holdings
8.7%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
242
Price
$32.47
Total Value
$7.86K
Shares Held After
25,655
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
4,525
Price
$32.01
Total Value
$144.83K
Shares Held After
25,897
% of Holdings
14.9%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
637
Price
$32.47
Total Value
$20.68K
Shares Held After
124,557
% of Holdings
0.5%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
11,930
Price
$32.01
Total Value
$381.85K
Shares Held After
125,194
% of Holdings
8.7%
STRYKER CORP (SYK)
King Debra — VP, Chief Digital and Information Officer
Shares
826
Price
$336.30
Total Value
$277.79K
Shares Held After
6,210
% of Holdings
11.7%
EyePoint, Inc. (EYPT)
Zaderej Karen L. — Director
Shares
10,600
Price
$4.93
Total Value
$52.26K
Shares Held After
49,100
% of Holdings
21.6%
Elanco Animal Health Inc (ELAN)
O'Neill Shiv — GC AND CORP SEC
Shares
3,998
Price
$23.58
Total Value
$94.27K
Shares Held After
87,832
% of Holdings
4.6%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
1,600
Price
$21.38
Total Value
$34.21K
Shares Held After
244,176
% of Holdings
0.7%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
12,586
Price
$20.94
Total Value
$263.49K
Shares Held After
245,776
% of Holdings
4.9%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.82
Total Value
$265.37K
Shares Held After
153,902
% of Holdings
2.2%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
2,030
Price
$4.92
Total Value
$9.99K
Shares Held After
8,587
% of Holdings
23.6%
Verrica Pharmaceuticals Inc. (VRCA)
Kirby John J. — Interim CFO
Shares
5,000
Price
$4.93
Total Value
$24.65K
Shares Held After
23,962
% of Holdings
20.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
9,000
Price
$5.54
Total Value
$49.86K
Shares Held After
3,096,000
% of Holdings
0.3%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
10,000
Price
$11.03
Total Value
$110.30K
Shares Held After
251,000
% of Holdings
4.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,100
Price
$59.35
Total Value
$65.28K
Shares Held After
25,000
% of Holdings
4.2%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
3,900
Price
$58.37
Total Value
$227.65K
Shares Held After
26,100
% of Holdings
13.0%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
3,749
Price
$19.94
Total Value
$74.76K
Shares Held After
39,900
% of Holdings
8.6%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
37,945
Price
$19.85
Total Value
$753.33K
Shares Held After
43,649
% of Holdings
46.5%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.27
Total Value
$10.27K
Shares Held After
19,592
% of Holdings
5.1%
Sotera Health Co (SHC)
Petras Michael B. Jr. — Director
Shares
850,000
Price
$18.50
Total Value
$15.73M
Shares Held After
3,969,393
% of Holdings
17.6%
Sotera Health Co (SHC)
Petras Michael B. Jr. — Director
Shares
294,515
Price
$18.50
Total Value
$5.45M
Shares Held After
397,912
% of Holdings
42.5%
Showing 1–50 of 403 transactions (page 1 of 9)